At the recent Meeting on the Mesa 2025 in Arizona, Autolomous CEO, Alexander Seyf, sat down with IBTV to discuss a major milestone in the push for industrial-scale advanced therapies.

The focus of the conversation was the release of a new joint white paper with the Cell and Gene Therapy (CGT) Catapult, detailing the results of a two-year collaboration aimed at fast-tracking digital transformation across the industry.